CI vs LSAK · P/E 2.4, rev $274.90B vs rev $659.7M
Cigna Corp (CI) versus Lesaka Technologies Inc (LSAK) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Lesaka Technologies Inc (LSAK) is a software - infrastructure company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported LSAK revenue for 2025-06-30 was $659.7M. Net income was -$87.6M. Revenue was up 16.9% from 2024-06-30 to 2025-06-30. LSAK currently screens at market cap $433.8M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. LSAK currently screens at market cap $433.8M.
Not investment advice. Open the CI and LSAK stock pages for the full models.
Not investment advice.